Boehringer Ingelheim and FEI partner to promote equine health and education 

Boehringer Ingelheim joins forces with partners around the world towards the elimination of rabies

Dr. Joyce Van Donkersgoed named as the 2017 Metacam^® 20* Bovine Welfare Award winner

Boehringer Ingelheim celebrates a decade of sharing perspectives on farm animal well-being

Boehringer Ingelheim: A New World Leader in Animal Health

Susan Blair appointed as Head of Boehringer Ingelheim Animal Health in Canada

Boehringer Ingelheim (Canada) Ltd. receives approval for Metacam^®* 20 for the reduction of pain associated with abdominal surgery in cattle

Dr. Ken Leslie named as the 2016 Metacam^® 20* Bovine Welfare Award winner

Boehringer Ingelheim (Canada) Ltd. receives approval for Metacam^®for Swine for relief of post-operative pain associated with soft tissue surgery such as castration

Boehringer Ingelheim (Canada) Ltd. receives approval for Metacam^® 20* for the alleviation of pain and inflammation in sheep

Boehringer Ingelheim (Canada) Ltd. announces winners of #PerfectWithoutPain video contest

Calf health from the calf’s perspective  

Boehringer Ingelheim (Canada) Ltd., launches ULTRA^™ Fel-O-Vax^®, the first and only ½ mL vaccine line for cats  

Boehringer Ingelheim Animal Health celebrates 20 years of
         PRRS control and innovation 

Semintra^®
New treatment for cats with chronic kidney disease: Boehringer Ingelheim (Canada) Ltd. launches Semintra^®

PRASCEND^® (pergolide mesylate) approved by the Veterinary Drug Directorate of Health Canada for treatment of pituitary pars intermedia dysfunction (PPID) in horses.